Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration ina rat model of embolic stroke - Zhang, L; Zhang, ZG; Zhang, R (Circulation, 2003)
et al.